Epic, LabCorp Team on Sample Prep for Clinical Trials | GenomeWeb

NEW YORK (GenomeWeb News) – Circulating tumor cell-based diagnostics firm Epic Sciences today announced an agreement with Laboratory Corporation of America aimed at speeding up sample processing for Epic's technology in support of European clinical trials.

LabCorp's Central Laboratory in Mechelen, Belgium will process samples for Epic's clinical trial partners and customers as part of the deal. The samples will then be sent to Epic's laboratory in La Jolla, Calif. for downstream detection and molecular characterization of CTCs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.